The Baja California Sur Congress has approved a motion urging health institutions like IMSS, ISSSTE, and IMSS-Bienestar to incorporate the medication vosoritide into their catalogs. The initiative seeks to establish clear authorization and treatment guidelines for children and adolescents with achondroplasia in the state.